ctrl K

Price Alert

Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

0.80

-0.05 (-5.77%)

At close: Aug 20, 2025, 3:59 PM

0.80

0.00%

After-hours: Aug 20, 2025, 04:00 PM EDT

Lexaria Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	6.5M	1.35M	5.81M	10.92M
Short-Term Investments	55.81K	125.64K	347.33K	833.84K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	63.58K	n/a	-856.41K	-823.88K
Receivables	154.48K	175.25K	201.78K	342.4K
Inventory	n/a	n/a	38.42K	29.65K
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	7.9M	2.2M	6.98M	12.44M
Property-Plant & Equipment	389.55K	421.59K	367.95K	459.25K
Goodwill & Intangibles	516.68K	462.63K	488.46K	364.62K
Total Long-Term Assets	969.8K	884.21K	856.41K	823.88K
Total Assets	8.87M	3.08M	7.83M	13.27M
Account Payables	371.35K	225.04K	25.85K	59.89K
Deferred Revenue	4.96K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	42.59K	7.93K
Other Current Liabilities	686.53K	n/a	51.71K	1.05K
Total Current Liabilities	1.1M	267.74K	194.04K	153.28K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	109.32K	136.17K	7.4K	49.99K
Total Liabilities	1.21M	403.91K	201.44K	203.26K
Total Debt	137.37K	163.97K	49.99K	97.32K
Common Stock	n/a	8.09K	5.95K	5.73K
Retained Earnings	-51.56M	-45.76M	-39.1M	-31.83M
Comprehensive Income	-19.82K	n/a	0.00	-0.00
Shareholders Equity	8.04M	3.04M	7.95M	13.27M
Total Investments	55.81K	125.64K	347.33K	833.84K